Table 1.
Baseline Characteristics by Adverse Pregnancy Outcome (n = 324)
| Characteristic | No APO (n = 245) | History of APO (n = 79) | p |
|---|---|---|---|
| Age | 56.3 ± 10.4 | 51.9 ± 9.1 | 0.001 |
| BMI | 29.3 ± 7.1 | 32.3 ± 10.1 | 0.004 |
| BSA | 1.8 ± 0.2 | 1.9 ± 0.3 | 0.003 |
| Pulse rate | 68.0 ± 10.6 | 69.7 ± 11.0 | 0.259 |
| Systolic BP | 126.4 ± 18.1 | 128.3 ± 17.6 | 0.452 |
| Diastolic BP | 67.2 ± 11.7 | 70.0 ± 13.1 | 0.090 |
| Total cholesterol | 181.9 ± 36.3 | 175.3 ± 36.9 | 0.307 |
| TRIG | 120.4 ± 78.6 | 130.4 ± 80.8 | 0.428 |
| HDL | 60.0 ± 16.7 | 57.3 ± 17.8 | 0.376 |
| LDL | 99.1 ± 32.8 | 93.3 ± 35.8 | 0.337 |
| Glucose | 96.6 ± 26.1 | 98.7 ± 25.2 | 0.640 |
| Creatinine | 0.78 ± 0.16 | 0.75 ± 0.17 | 0.432 |
| History of hypertension (%) | 88 (36) | 45 (56) | 0.002 |
| ACE-I | 48 (21) | 17 (22) | 0.873 |
| ARB | 16 (7) | 9 (12) | 0.228 |
| Beta blocker | 72 (31) | 30 (38) | 0.267 |
| Calcium channel blocker | 53 (23) | 21 (27) | 0.441 |
| Diuretic | 31 (13) | 14 (18) | 0.350 |
| Vasodilator | 10 (4) | 3 (4) | 1.0 |
| Race | 0.841 | ||
| Native American | 2 (1) | 1 (1) | |
| Asian/Pacific Islander | 6 (2) | 3 (4) | |
| Black/African American | 18 (7) | 7 (9) | |
| Hispanic/Latin | 22 (9) | 6 (8) | |
| White/Not Hispanic | 183 (75) | 59 (75) | |
| Other/specify | 14 (6) | 2 (3) |
Data values are represented as mean ± SD or n (%).
ACE-I, ace-inhibitor; APO, adverse pregnancy outcome; ARB, angiotensin receptor blocker; BMI, body mass index; BP, blood pressure; BSA, body surface area; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SD, standard deviation; TRIG, triglycerides.